You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)委任吳以芳為董事長;委任關曉暉為執行總裁兼首席財務官
格隆匯 10-29 17:54

格隆匯 10 月 29日丨復星醫藥(02196.HK)公佈,於2020年10月29日,集團董事會收到執行董事陳啟宇及姚方的辭職函,陳啟宇因工作安排調整,辭任公司第八屆董事會董事長;及香港聯交所證券上市規則第3.05條項下公司授權代表("授權代表")。姚方因工作安排調整,辭任公司聯席董事長職務。根據公司章程規定,陳啟宇及姚方的辭任自2020年10月29日起生效。

同日宣佈,選舉執行董事吳以芳為董事長,任期自2020年10月29日起至第八屆董事會任期屆滿止。根據公司章程規定,吳以芳將擔任公司法定代表人。董事會亦宣佈委任吳以芳為授權代表,自2020年10月29日起生效,吳以芳將與甘美霞共同履行授權代表相關職責。此外陳啟宇及姚方由執行董事改任為非執行董事,彼等任期自2020年10月29日起至第八屆董事會任期屆滿止。

於2020年10月29日,董事會收到吳以芳的辭任函,以辭任公司總裁職務,其辭任自辭任函送達董事會時生效。辭任總裁後,吳以芳將擔任執行董事、董事長及首席執行官。

同日,根據首席執行官提名,董事會聘任陳玉卿、王可心及李東明為公司聯席總裁,聘任關曉暉為公司執行總裁兼首席財務官,任期均自2020年10月29日起至本屆董事會任期屆滿之日止。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account